PCM
Perkins Capital Management Portfolio holdings
AUM
$99.5M
This Quarter Return
+0.18%
1 Year Return
+49.19%
3 Year Return
+174.89%
5 Year Return
+322.89%
10 Year Return
–
AUM
$89.4M
AUM Growth
+$89.4M
(-7.5%)
Cap. Flow
+$908K
Cap. Flow
% of AUM
1.02%
Top 10 Holdings %
Top 10 Hldgs %
34.76%
Holding
112
New
7
Increased
13
Reduced
63
Closed
8
Top Buys
| 1 |
LeMaitre Vascular
LMAT
|
$1.97M |
| 2 |
TELA Bio
TELA
|
$1.48M |
| 3 |
VJET
VOXELJET AG American Depositary Shares (each representing one Ordinary Share)
VJET
|
$458K |
| 4 |
Backblaze
BLZE
|
$366K |
| 5 |
Ionis Pharmaceuticals
IONS
|
$283K |
Top Sells
| 1 |
SMED
Sharps Compliance Corp
SMED
|
$552K |
| 2 |
AquaBounty Technologies
AQB
|
$510K |
| 3 |
Digi International
DGII
|
$222K |
| 4 |
Lumen
LUMN
|
$144K |
| 5 |
Modular Medical
MODD
|
$130K |
Sector Composition
| 1 | Healthcare | 57.4% |
| 2 | Technology | 19.81% |
| 3 | Communication Services | 7.23% |
| 4 | Industrials | 7.09% |
| 5 | Consumer Staples | 4.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PFIE
26
DELISTED
Profire Energy, Inc
PFIE
| $1.24M | 1.38% |
1,453,515
-100,865
| -6% | -$85.8K |
|
|
EGIO
27
DELISTED
Edgio, Inc. Common Stock
EGIO
| $1.21M | 1.35% |
435,000
-20,000
| -4% | -$55.6K |
|
28
Target
TGT
$42B
| $1.15M | 1.28% |
7,729
-50
| -0.6% | -$7.42K |
|
29
Bristol-Myers Squibb
BMY
$96.7B
| $1.11M | 1.24% |
15,641
-867
| -5% | -$61.6K |
|
30
Merck
MRK
$210B
| $1.03M | 1.15% |
11,925
-100
| -0.8% | -$8.61K |
|
31
CareDx
CDNA
$678M
| $969K | 1.08% |
56,942
-1,550
| -3% | -$26.4K |
|
32
Cantaloupe
CTLP
$795M
| $923K | 1.03% |
265,350
-4,775
| -2% | -$16.6K |
|
33
Magnite
MGNI
$3.49B
| $894K | 1% |
136,075
+50
| +0% | +$328 |
|
34
Gilead Sciences
GILD
$140B
| $883K | 0.99% |
14,317
-1,300
| -8% | -$80.2K |
|
|
PDCO
35
DELISTED
Patterson Companies, Inc.
PDCO
| $864K | 0.97% |
35,950
-1,250
| -3% | -$30K |
|
36
Vericel Corp
VCEL
$1.69B
| $844K | 0.94% |
36,367
| – | – |
|
37
Castle Biosciences
CSTL
$673M
| $811K | 0.91% |
31,110
-2,060
| -6% | -$53.7K |
|
38
BioLife Solutions
BLFS
$1.2B
| $728K | 0.81% |
32,000
| – | – |
|
39
Ciena
CIEN
$13.4B
| $728K | 0.81% |
18,000
| – | – |
|
40
Achieve Life Sciences
ACHV
$146M
| $720K | 0.81% |
218,100
-10,000
| -4% | -$33K |
|
41
Exagen
XGN
$213M
| $698K | 0.78% |
257,455
+20,480
| +9% | +$55.5K |
|
42
Fortress Biotech
FBIO
$87.8M
| $682K | 0.76% |
792,513
+31,521
| +4% | +$27.1K |
|
43
3M
MMM
$81B
| $678K | 0.76% |
6,137
-165
| -3% | -$18.2K |
|
44
Perspective Therapeutics
CATX
$251M
| $655K | 0.73% |
2,850,644
-63,856
| -2% | -$14.7K |
|
|
AUGX
45
DELISTED
Augmedix, Inc. Common Stock
AUGX
| $648K | 0.73% |
446,900
+7,400
| +2% | +$10.7K |
|
46
Apple
AAPL
$3.54T
| $643K | 0.72% |
4,650
| – | – |
|
|
AKTS
47
DELISTED
AKOUSTIS TECHNOLOGIES, INC.
AKTS
| $643K | 0.72% |
216,450
-9,500
| -4% | -$28.2K |
|
|
SRXH
48
SRX Health Solutions, Inc.
SRXH
$13.3M
| $626K | 0.7% |
786,834
-55,416
| -7% | -$44.1K |
|
49
Verizon
VZ
$184B
| $623K | 0.7% |
16,417
-1,000
| -6% | -$37.9K |
|
50
AT&T
T
$208B
| $602K | 0.67% |
39,242
-2,295
| -6% | -$35.2K |
|